News

Bid to end excessive waiting stands 'no chance' of success

03-Jan-08

The government’s proposals to eliminate excessive waiting from the NHS stand no realistic chance of succeeding, according to a report from an independent think tank.

Civitas blames primary care organisations and GPs in the report Why are we waiting? 

It says the utilisation of independent sector treatment centres is still below capacity despite all the evidence pointing to better standards of care.

It says the number of patients who recalled being offered a choice of hospital for their first outpatient appointment actually fell by 5 per cent between March and July 2007 to 43 per cent.

Just 45 per cent of GP referrals use the Choose and Book system.

James Gubb, director of the Civitas health unit, said: ‘It must now be down to PCTs and GPs to encourage choice and competition. For the benefits of competition to be realised, and for waiting times to really accelerate downwards, the reluctance of commissioners to use independent providers at the expense of established NHS providers has to change.’

neil.durham@haymarket.com

Comment below and tell us what you think

See all commented articles in our Forums and Blogs section

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Jobs

 

Job of the Week

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more